~~<i id='65575F94F4'><strike id='65575F94F4'><tt id='65575F94F4'><pre id='65575F94F4'></pre></tt></strike></i>~~

Home» comprehensive» explore

explore

author：fashion 2025-09-29 14:37:11 Page View：77

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Travis Kelce and the trap of celebrity vaccine endorsements
Next article： In age of alternative facts, a scholarly course on calling out crap

leisure time

Tori Bowie and the unacceptable rates of Black maternal death

AlastairGrant/APThehorrorstoriesofBlackwomendyingorcomingclosetodeathinchildbirthneverseemtostopcomi

Leon Gautier, last member of French D

FILE-FrenchPresidentEmmanuelMacronspeakswithLeonGautier,aFrenchWWIIveteranoftheCommandoKieffer,durin

Psychedelics group wrestles with new pharma identity

OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

10 states plan to sue EPA over standards for residential wood

DonSakischecksthefireinhisRitewaywoodstoveathishomeonJan.23,2018,inPalmer,Alaska.Sakisandhisfamilyha